A5058426443- CAR-T cell therapy research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Acute Myeloid Leukemia Research
- Economic and Financial Impacts of Cancer
- Chronic Myeloid Leukemia Treatments
- Cancer survivorship and care
- Heparin-Induced Thrombocytopenia and Thrombosis
- Childhood Cancer Survivors' Quality of Life
- Acute Myocardial Infarction Research
- Immune Cell Function and Interaction
- Venous Thromboembolism Diagnosis and Management
- Flame retardant materials and properties
- Immunotherapy and Immune Responses
- Health Systems, Economic Evaluations, Quality of Life
- Palliative Care and End-of-Life Issues
- Diverse Music Education Insights
- Reproductive Biology and Fertility
- Biomedical Ethics and Regulation
- Music Education and Analysis
- Eosinophilic Disorders and Syndromes
- Musicians’ Health and Performance
RTI Health Solutions
2025
Syneos Health (United States)
2019-2022
George Washington University
2019-2022
Maharaj Institute of Immune Regenerative Medicine
2017
Watertown City School District
1996
Brightwood College
1996
Evanston Hospital
1996
e19142 Background: Patient-reported outcomes (PROs) are an important tool to assess the impact of new therapies on health-related quality life (HRQoL). This study aimed describe if and what PRO instruments currently being utilized in CAR-T cell therapy studies solid hematological malignancies while assessing patterns inclusion trends HRQoL data reporting. Methods: We used Citeline search for clinical trials between Jan 2008 - 2020, excluding planned or terminated studies, non-oncology,...